Concurrent Systems Revenue and Competitors

Newbury, UK

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Concurrent Systems's estimated annual revenue is currently $1.3M per year.(i)
  • Concurrent Systems's estimated revenue per employee is $87,000

Employee Data

  • Concurrent Systems has 15 Employees.(i)

Concurrent Systems's People

NameTitleEmail/Phone
1
CEO and PLM ConsultantReveal Email/Phone
2
Development DirectorReveal Email/Phone
3
Technical DirectorReveal Email/Phone
4
Operations ManagerReveal Email/Phone
5
Contracts ManagerReveal Email/Phone
6
Marketing ExecutiveReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.5M7N/AN/AN/A
#2
$3720M129340%$26.5M$1.2B
#3
$33.7M211N/AN/AN/A
#4
$20M1385%$18.2MN/A
#5
$31.6M198-2%N/AN/A
#6
$69.8M385N/AN/AN/A
#7
$7.1M56-14%$7.5MN/A
#8
$46.3M297-12%$109MN/A
#9
$14.8M102-3%N/AN/A
#10
$12.8M88N/AN/AN/A
#11
$5.1M44N/AN/AN/A
#12
$125.2M6800%$138.2MN/A
#13
$34.4M86N/AN/AN/A
#14
$9.5M49N/AN/AN/A
#15
$38.9M244N/AN/AN/A
#16
$2.7M27N/AN/AN/A
#17
$164M808N/AN/AN/A
#18
$347.4M1128N/AN/AN/A
#19
$0.6M8N/AN/AN/A
#20
$4M36-32%$21.4MN/A
Add Company

What Is Concurrent Systems?

keywords:N/A

N/A

Total Funding

15

Number of Employees

$1.3M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Concurrent Systems News

2022-04-20 - Qvella FAST System and FAST-PBC Prep Cartridge Get CE ...

Qvella FAST System and FAST-PBC Prep Cartridge Get CE Marked and FDA Listed for In Vitro Diagnostic Use · Qvella · Concurrent with the marketing...

2022-04-20 - Qvella Obtains CE Mark, FDA Listing for Blood Culture ...

The system and prep cartridge are fully automated technologies to ... Concurrent with the marketing authorization and commercialization of...

2022-04-20 - VOLUNTEER, DESIGN, BUILD

Designing was concurrent with constructing, systems were tried out along the project, details were sketched at site and materials were...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M150%N/A
#2
$1.3M1567%N/A
#3
$4.8M21-74%N/A
#4
$2.8M22-51%N/A
#5
N/A2567%N/A